※ Please refer to this page for the set with sampler.
Inquiries about products
E-mail:st_support@cellspect.com
TEL:019-681-2088
Telephone reception hours: Weekdays 9:00 to 17:00 (excluding Saturdays, Sundays, and holidays)
※ In case of accidental occurrence of research activities, such as detection of antibodies suspected of infection cases, please consult with your local government as we are unable to provide support.
Inquiries about products
E-mail:st_support@cellspect.com
TEL:019-681-2088
Telephone reception hours: Weekdays 9:00 to 17:00 (excluding Saturdays, Sundays, and holidays)
※ In case of accidental occurrence of research activities, such as detection of antibodies suspected of infection cases, please consult with your local government as we are unable to provide support.
This product is not an in-vitro diagnostic drug. It cannot be used for diagnostic or therapeutic purposes. This product is intended for research use only.
<Precautions when purchasing research products>
・This product is for research use. Please check the instruction manual and the operation video in advance, and be aware of the following risks that the exact operation may not be achieved due to the variation of user's skill.
・The warranty does not cover operational errors or blood sampling failure due to individual characteristics (easy to clot, easy to bleed a lot, etc.).
(For inquiries regarding lancets, please contact the medical device manufacturer listed on the package insert that came with the lancet product.)
・The handling of collection capillaries and lancets (medical device) does not necessarily guarantee smooth blood collection in all cases due to individual differences.
・The detection kit is based on the test conditions in the user's manual and academic information, and does not guarantee the same performance in all cases.
<To companies handling this product and those considering purchasing this product>
This product is not a medical device but a research product (miscellaneous goods), so it does not fall under the Act on Pharmaceutical and Medical Devices. Therefore, it is clearly stated that it cannot be used for diagnostic or therapeutic purposes.
With the release of this product, it is expected that the scope of the research will expand and become more diverse due to the high level of social concern. Therefore, we ask the distributors to thoroughly explain the above, and from the viewpoint of consumer protection, misidentification of medical devices and research products, and disadvantages to consumers due to unintended use will not occur. We are proceeding with discussions and collaboration with related organizations regarding more desirable display and distribution styles.
We will continue to do our utmost to ensure that our products will continue to be used as research products properly. We kindly ask for your understanding and cooperation.
Features
・Made in Japan
・Minimally invasive sample volume as of only 10 μL
・Apply the blood directly
・All necessary reagents are included in the kit.
・Measurement time is only 15 minutes.
Main specifications of the products
Method of measurement: Immunochromatography
Samples of measurement: Whole blood, serum, plasma
Sample volume: 10 μL
Measurement time: 15 minutes
Storage temperature: 2 -8 ℃
Expiration date: This product is valid for 6 months after production.
Kit contents
・Test stick × 1 stick
・Reagent ×1 bottle
・Capillary (for dropping of 10 μL sample) ×2 pieces
※ Disinfectant cotton, puncture tools, and bandages are not included.
×1枚
×1本
×2本
Operation
Be sure to read the instruction manual before use.
-
Open the kit and take out the items beforehand.
The capillary is made of glass and fragile.
Please handle with care.
2. Puncture a cleanly washed finger with a lancet.
※Lancet is not included in this product.
Use the lancet correctly according to the instructions provided with the lancet product.
3. Press your fingertips gently to extract the amount of blood equal to a grain of rice.
4. The attached capillary is tilted and allowed to touch and aspirate the blood.
Aspirate until the capillaries are all filled and stop the puncture.
5. Touch the capillary vertically and gently to the sample addition part (A) of the test stick and then release it. Repeat this until all the samples have penetrated into A.
6. Add 3 drops of reagent to the sample addition part (A).
7. Let sit for 15 minutes. Read the judgment window.
Detected
Antibody reacted
Not detected
No antibody reaction
Measurement principle
1. When an IgG antibody of SARS-CoV -2 is present in the sample, an antigen-antibody reaction occurs with a recombinant SARS-CoV-2 nucleocapsid protein sensitized with gold colloid on a conjugate pad.
2. The antigen-antibody complex moves toward the membrane.
3. The flowing complex binds to the anti-human IgG antibody on the membrane.
4. As a result, a red line can be seen in the judgment window.
5. This line is not detected when the SARS-CoV-2 IgG antibody is not present in the sample.
Significance of measurement
This kit is a research immunochromatographic kit for detecting human IgG antibodies recognizing the nucleocapsid protein of SARS-CoV-2, which is the causative virus of COVID -19. Virus detection can be broadly divided into two approaches: one is to detect the virus itself, such as PCR method, and the other is to detect the immune response that develops during infection (IgG, IgM, IgA, etc.) In COVID -19, the production of IgM antibodies have not always been confirmed in all infected persons, whereas IgG antibodies have been reported to be produced in many cases regardless of the severity of symptoms. The production of IgG antibodies has been observed in approximately 60 ~ 80% of the infected group around 10 days after the onset, and is confirmed in most of the infected group 14 days after the onset. The persistence of IgG antibodies has been maintained for at least 30 days after onset in many cases, but there are insufficient reports on the details, and further clarification is required.
Related literature
-
S. J. C. Pallett et al.
Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population
Sci Rep. 2021 Mar. 2021 Feb. PubMed PMID: 33712679
Arch Pathol Lab Med . 2021 Jan. PubMed PMID: 32966561
-
Renee L Higgins et al.
Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay
PLoS One. 2021 Mar. PubMed PMID: 33661960
-
Jose Tuells et al.
Seroprevalence Study and Cross-Sectional Survey on COVID-19 for a Plan to Reopen the University of Alicante (Spain)
Int J Environ Res Public Health. 2021 Feb. PubMed PMID: 33669412
-
Charlotte Charpentier et al.
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
J Clin Virol. 2020 Nov. PubMed PMID: 32919222
-
Tao Peng et al.
Point-of-care test system for detection of immunoglobulin-G and -M against nucleocapsid protein and spike glycoprotein of SARS-CoV-2
Sens Actuators B Chem. 2021 Mar. PubMed PMID: 33519091
-
Hélène Péré et al.
Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests
J Virol Methods. 2021 Apr. PubMed PMID: 33476707
-
Larry L. Luchsinger et al.
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
J Clin Microbiol. 2020 Dec. PubMed PMID: 32917729
-
Jannie Laursen et al.
Prevalence of SARS-CoV-2 IgG/IgM Antibodies among Danish and Swedish Falck Emergency and Non-Emergency Healthcare Workers
Int J Environ Res Public Health. 2021 Jan. PubMed PMID: 33494409
-
Steven E Conklin et al.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing
J Clin Microbiol. 2021 Jan. PubMed PMID: 33208477
-
Mario Plebani et al.
Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study
J Clin Microbiol. 2021 Jan. PubMed PMID: 33218990
-
Massimo Ralli et al.
Assessment of SARS-CoV-2 infection through rapid serology testing in the homeless population in the City of Rome, Italy. Preliminary results
J Public Health Res. 2020 Oct 14. PubMed PMID: 33409245
-
Rahul Batra et al.
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
J Clin Virol. 2020 Nov. PubMed PMID: 32961429
-
Alberto Zambelli et al.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic
Oncologist. 2020 Dec 23. PubMed PMID: 33355953
-
Vieri Lastrucci et al.
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)
Vaccines (Basel). 2020 Dec. PubMed PMID: 33352743
-
Jialin Xiang et al.
Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection
BMC Infect Dis. 2020 Oct 20. PubMed PMID: 33081702
-
Barnaby Flower et al.
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey
Thorax. 2020 Aug. PubMed PMID: 32796119
-
Reham Abdelmoniem et al.
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility
J Clin Virol . 2020 Nov 27. PubMed PMID: 33276180
-
María Simón Sacristan et al.
Comparison of various serological assays for novel SARS-COV-2
Eur J Clin Microbiol Infect Dis. 2020 Nov 25. PubMed PMID: 33236270
-
Ronan Garlantézec et al.
A Lateral Flow Immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers
Emerg Microbes Infect. 2020 Nov 18. PubMed PMID: 33206004
-
Martin Risch et al.
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Biomed Res Int. 2020. PubMed PMID: 33224987
-
Jacob T Heggestad et al.
Multiplexed, quantitative serological profiling of COVID-19 from a drop of blood by a point-of-care test
medRxiv. Preprint. 2020 Nov 7. PubMed PMID: 33173900
-
Wemboo Afiwa Halatoko et al.
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
PLoS One. 2020 Nov 9. PubMed PMID: 33166369
-
Clarence W Chan et al.
Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection
Am J Clin Pathol . 2020 Nov 2. PubMed PMID: 33135049
-
Diana Canetti et al.
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic
PLoS One. 2020 Nov 2. PubMed PMID: 33137138
-
Zahra Rikhtegaran Tehrani et al.
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
PLoS One. 2020 Nov 2. PubMed PMID: 33137138
-
Yang De Marinis et al.
Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody test
Infect Ecol Epidemiol. 2020 Sep 20. PubMed PMID: 33062217
-
Mengting Liao et al.
Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China
J Clin Lab Anal. 2020 Oct 16. PubMed PMID: 33067888
-
Qing-Bin Meng et al.
Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid
World J Clin Cases. 2020 Oct 6. PubMed PMID: 33083395
-
Zhaoqing Lyu et al.
Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan
Diseases. 2020 Sep 23. PubMed PMID: 32977485
-
Alessandra Sperotto et al.
Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up
J Med Virol. 2020 Oct 8. PubMed PMID: 33030745
-
Ana Dacosta-Urbieta et al.
Seroprevalence of SARS-CoV-2 Among Pediatric Healthcare Workers in Spain
Front Pediatr. 2020 Sep 11. PubMed PMID: 33042908
-
Lysandro Pinto Borges et al.
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
Rev Panam Salud Publica. 2020 Oct 6. PubMed PMID: 33042199
-
Gláucia Cota et al.
Diagnostic performance of commercially available COVID-19 serology tests in Brazil
Int J Infect Dis. 2020 Oct 9. PubMed PMID: 33039612
-
Angelo Virgilio Paradiso et al.
Rapid serological and SARS-CoV-2 RT-PCR assays: comparison performed simultaneously in symptomatic COVID-19 patients
J Med Internet Res. 2020 Sep 13. PubMed PMID: 33031048
-
Hidetsugu Fujigaki et al.
Reliability of serological tests for COVID-19: comparison of three immunochromatography test kits for SARS-CoV-2 antibodies
Heliyon. 2020 Sep 10. PubMed PMID: 32984615
-
Rafael V. Picon et al.
Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil
Ent J Infect Dis. 2020 Sep. PubMed PMID: 32949778
-
Shey-Ying Chen et al.
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
Emerg Microbes Infect. 2020 Sep 17. PubMed PMID: 32940547
-
Luis Cabezón-Gutiérrez et al.
Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data
Cancer Treat Rev. 2020 Sep. PubMed PMID: 32947121
-
Suzanne Pickering et al.
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
PLoS Pathog . 2020 Sep 24. PubMed PMID: 32970782
-
Laurent Dortet et al.
Rapid Determination of SARS-CoV-2 Antibodies Using a Bedside, Point-of-Care, Serological Test
Emerg Microbes Infect. 2020 Sep. PubMed PMID: 32969769
-
Grazia Arpino et al.
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era
ESMO Open. 2020 Sep. PubMed PMID: 32958531
-
Diego O. Andrey et al.
Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests
J Clin Med. 2020 Aug. PubMed PMID: 32722191
-
Irene García García et al.
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial
Trials. 2020 Jun 3. PubMed PMID: 32493475
-
Georg M. N. Behrens et al.
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
Infect Dis Ther. 2020 Sep 4. PubMed PMID: 32886335
-
Oktavija Đaković Rode et al.
Antibody response and the clinical presentation of patients with COVID-19 in Croatia: the importance of a two-step testing approach
Eur J Clin Microbiol Infect Dis. 2020 Sep 4. PubMed PMID: 32886230
-
Scott J C Pallett et al.
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study
Lancet Respir Med. 2020 Jul 24. PubMed PMID: 32717210
-
Yuwen He et al.
Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019
Front Cell Infect Microbiol. 2020 Aug 6. PubMed PMID: 32850506
-
Baptiste Demey et al.
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays
J Infect. 2020 Aug. PubMed PMID: 32389784
-
Felipe Pérez-García et al.
Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study
J Clin Virol. 2020 Aug. PubMed PMID: 32504945
-
Isabel Montesinos et al.
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies
J Clin Virol. 2020 Jul. PubMed PMID: 32403010
-
Jitendra Prasad Mathuria et al.
Laboratory diagnosis of SARS-CoV-2 - A review of current methods
J Infect Public Health. 2020 Jul. PubMed PMID: 32534946
-
Yunbao Pan et al.
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients
J Infect. 2020 Jul. PubMed PMID: 32283141
-
Carmen L Charlton et al.
Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
J Clin Microbiol. 2020 Jul 14. PubMed PMID: 32665420
-
Antonio Vittorino Gaddi et al.
The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors
Int J Mol Sci. 2020 Jun. PubMed PMID: 32580529
-
Jonathan J Deeks et al.
Antibody tests for identification of current and past infection with SARS-CoV-2
Cochrane Database Syst Rev. 2020 Jun 25. PubMed PMID: 32584464
-
Andrea P Espejo et al.
Review of Current Advances in Serologic Testing for COVID-19
Am J Clin Pathol. 2020 Jun 25. PubMed PMID: 32583852
-
Jhong-Lin Wu et al.
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2
J Infect. 2020 Jun 15. PubMed PMID: 32553841
-
M Döhla et al.
Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity
Public Health. 2020 May. PubMed PMID: 32334183
References
1.)Keiichi Hiramatsu, Standard Textbook of standard microbiology, 11th edition, Medical study (2012)
2.)Anu Haveri , “Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland,” January to February 2020 , Eurosurveillance. Volume 25, Issue 11, 19, Mar 2020.
3.)Wanbing Liu, “Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2”, J Clin Microbiol. 2020 Mar 30.
4.)Li Guo, “Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)”, Clin Infect Dis. 2020 Mar 21.
5.)Juanjuan Zhao, “Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019”, Clin Infect Dis. 2020 Mar 21.
6.)Grzelak et al, "SARS-CoV-2 Serological Analysis of COVID-19 Hospitalized Patients, Pauci-Symptomatic Individuals and Blood Donors". (Infectious Diseases (except HIV/AIDS), 24 April 2020)
7.)Liu et al, "Evaluation of Nucleocapsid and Spike Protein-Based ELISAs for Detecting Antibodies against SARS-CoV-2", Journal of Clinical Microbiology, 2020, JCM.00461-20, jcm;JCM.00461-20v1
8.)Sun et al, "Kinetics of SARS-CoV-2 Specific IgM and IgG Responses in COVID-19 Patients", Emerging Microbes & Infections, 9.1 (2020), 940–48
Q&A
This information is only a general example and does not guarantee its effectiveness. We are not responsible for loss resulting from this information. Please use the lancet properly according to the package insert. For more information about lancets and how to use lancets, please contact the manufacturer listed on the lancet product documentation.
Q. I have difficulty in getting blood.
A. Please make sure to promote blood circulation before puncture. If you open and close your hands below the heart or rub the finger to puncture, blood will easily come out. If you have a cold condition, warming your hands with a body warmer may make it easier for blood to come out. However, there are individual differences in technique and condition, so please understand that puncture and blood collection may not always be possible (For puncture operations, contact the manufacturers listed on the lancet package insert.)
Q. I have so much blood that I can't make it the size of a grain of rice.
A. Wipe the blood with a clean item such as clean cotton and slowly make a blood ball again. If the tip of the capillary is exposed to a large amount of blood (the state of not being the size of a grain of rice), it may be difficult to aspirate blood into the capillary.)
Q. I have a lot of blood and it doesn't stop.
A. If you are concerned about puncture bleeding, consult the manufacturer of the Lancet product and your doctor.
Q. The capillary doesn’t work very well.
A. Watch the video (https://www.cellspect.com/igg-lf-nucleocapsidprotein). If you make blood the size of a grain of rice and bring the tip of the capillary slowly from the bottom diagonally into contact with the blood, the suction will start naturally.
(If the end of the capillary is lower than the tip, it is easier to suck. It is important to place the capillary handle below the fingertip.) Add blood quickly to the stick to prevent it from clotting.
Q. Capillary does not fit into the test stick well.
A. Please watch the video (https://www.cellspect.com/igg-lf-nucleocapsidprotein). Once the blood clots, it may not be possible to penetrate the sticks later. In this case, collect blood again using the spare capillary and re- operate immediately. When permeating the sample from the capillary into the sample addition part, repeat the capillary up and down (attach and detach) several times evenly, and let the whole volume soak. It may not possible to infiltrate the entire volume. If it is possible to infiltrate more than 1/3 of the blood in the capillaries, the performance of this product will not be significantly affected. Therefore, immediately after this procedure, add 3 drops of reagent and carry out the detection procedure.
Q. I added a reagent, but I can't see it flow into the judgment window.
A. There is a possibility that the amount of reagent is insufficient. Add 1 -2 drops of the reagent immediately. Within one minute, the sheet of the judgment window starts to get wet, and you can see the line at the end of detection. When adding the reagent, make sure that the droplet has been dropped onto the sample addition part.
In rare cases, large bubbles may be contained in the droplets. In this case, the drop volume may be less than the actual drop. If 1 -2 drops is added immediately, the sheet of the judgment window will get wet within 2 minutes. Check the line at the end of detection. If the sheet of the judgment window is not wet, the line at the end of detection will not appear even after several minutes.
Q. When using pipettes or another company's capillary
A. The amount of blood is 10 μl. Carefully collect the sample so as not to cause hemolysis, and add it slowly to the sample addition part. Please note that some items may cause hemolysis depending on the handling method of other companies' droppers and pipettes. When adding a hemolyzed sample, false positives may be detected in rare cases, so please be careful when interpreting the results
If above suggestions still don't work, please send an photo of the entire stick to our company support center (st_support@cellspect.com).